The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes

Keyphrases

• Clinical Trials 100%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Randomized Clinical Trial 100%
• Treatment Group 100%
• Type 2 Diabetes Prevention 100%
• Program Design 100%
• Diabetes Prevention Program 100%
• Programming Method 100%
• Diet Recommendation 100%
• Exercise Recommendation 100%
• Cell Function 50%
• High-risk Individuals 50%
• Cardiovascular Disease 50%
• Diabetes 50%
• Obesity 50%
• Insulin Sensitivity 50%
• Placebo 50%
• Risk Factors 50%
• High Risk 50%
• Physical Activity 50%
• Diabetes Incidence 50%
• Health-related Quality of Life 50%
• Physical Health 50%
• Intervention Group 50%
• Adverse Events 50%
• Impaired Glucose Tolerance 50%
• Fasting Plasma Glucose 50%
• Plasma Glucose 50%
• Medication Treatment 50%
• Clinical Centers 50%
• Placebo Groups 50%
• Incidence Rate 50%
• Intensive Lifestyle Intervention 50%
• Glycemia 50%
• Metformin 50%
• Healthy Diet 50%
• Post-challenge 50%
• Troglitazone 50%
• 3 to 5 Years 50%
• Minority Patients 50%
• Association Criterion 50%
• Closing Date 50%
• Liver Toxicity 50%
• Testing Strategy 50%
• American Diabetes Association 50%

Medicine and Dentistry

• Clinical Trial 100%
• Diabetes 100%
• Maturity Onset Diabetes of the Young 100%
• Diabetes Prevention 100%
• Placebo 66%
• Treatment Group 66%
• Randomized Clinical Trials 66%
• Adverse Event 33%
• Insulin Sensitivity 33%
• Cardiovascular Disease 33%
• Physical Activity 33%
• Quality of Life 33%
• Cell Function 33%
• Impaired Glucose Tolerance 33%
• Lifestyle Intervention 33%
• Glycon 33%
• Liver Toxicity 33%
• Troglitazone 33%
• Healthy Diet 33%
• Primary Outcome 33%